• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性手部湿疹患者瘙痒和疼痛的患病率及特征

Prevalence and Characteristics of Itch and Pain in Patients Suffering from Chronic Hand Eczema.

作者信息

Zalewski Adam, Krajewski Piotr K, Szepietowski Jacek C

机构信息

Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-368 Wroclaw, Poland.

出版信息

J Clin Med. 2023 Jun 21;12(13):4198. doi: 10.3390/jcm12134198.

DOI:10.3390/jcm12134198
PMID:37445233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10342696/
Abstract

BACKGROUND

Hand eczema (HE) is a frequent chronic inflammatory dermatosis. Itch and pain are considered two of the most common and burdensome symptoms of the disease. Yet, the data related to these symptoms are still limited. The aim of this study was to evaluate characteristics of itch and pain in adults suffering from HE.

METHODS

The study group comprised 100 adult HE patients. An original questionnaire designed by the authors was used to survey the patients. It included questions regarding demographic characteristics such as the duration of the disease, exacerbation count, past diagnostics and treatment, as well as atopic predispositions. Additionally, the itch and pain intensity (numerical rating scale-NRS) during '3 days prior to the study' and the 'entire disease' period was implemented. The clinical assessment of the disease severity was performed according to two specific measurement instruments: Investigator Global Assessment for Chronic Hand Eczema (IGA-CHE) scale and Hand Eczema Severity Index (HECSI). To assess patient quality of life (QoL), the DLQI tool was used and to determine the level of stigmatization and for its impact on patients' life the 6-Item Stigmatization Scale (6-ISS) was employed.

RESULTS

Within the period of 3 days prior to the examination, itch was reported by 81.0% of patients ( = 81), whereas 53.0% ( = 53) of them experienced pain. Both symptoms were reported more frequently in females (itch: = 0.022; pain: = 0.033). When sexes were compared, females reached higher scores in both IGA-CHE and HECSI. Itch and pain intensity correlated positively with disease severity. The intensity of itch and pain significantly influences HE patients' QoL. A positive correlation between the 6-ISS score and the intensity of itch in the 'last 3 days' period was revealed (r = 0.221; = 0.027).

CONCLUSIONS

Itch and pain are common symptoms in HE patients, significantly contributing to the feeling of stigmatization. Providing characteristics of itch and pain may improve HE management. Symptom-decreasing treatment would definitely have a positive influence on patients' well-being.

摘要

背景

手部湿疹(HE)是一种常见的慢性炎症性皮肤病。瘙痒和疼痛被认为是该疾病最常见且最令人困扰的两种症状。然而,与这些症状相关的数据仍然有限。本研究的目的是评估成年手部湿疹患者的瘙痒和疼痛特征。

方法

研究组包括100名成年手部湿疹患者。使用作者设计的原始问卷对患者进行调查。问卷包括有关人口统计学特征的问题,如疾病持续时间、病情加重次数、既往诊断和治疗情况,以及特应性易感性。此外,还采用了“研究前3天”和“整个疾病期”的瘙痒和疼痛强度(数字评分量表-NRS)。根据两种特定的测量工具对疾病严重程度进行临床评估:慢性手部湿疹研究者整体评估(IGA-CHE)量表和手部湿疹严重指数(HECSI)。为评估患者的生活质量(QoL),使用了DLQI工具,并采用6项污名化量表(6-ISS)来确定污名化程度及其对患者生活的影响。

结果

在检查前3天内,81.0%(n = 81)的患者报告有瘙痒,而其中53.0%(n = 53)的患者经历过疼痛。两种症状在女性中报告的频率更高(瘙痒:P = 0.022;疼痛:P = 0.033)。比较性别时,女性在IGA-CHE和HECSI中得分更高。瘙痒和疼痛强度与疾病严重程度呈正相关。瘙痒和疼痛强度显著影响手部湿疹患者的生活质量。在“最后3天”期间,6-ISS评分与瘙痒强度之间存在正相关(r = 0.221;P = 0.027)。

结论

瘙痒和疼痛是手部湿疹患者的常见症状,显著加重了污名化感。提供瘙痒和疼痛的特征可能会改善手部湿疹的管理。减轻症状的治疗肯定会对患者的幸福感产生积极影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27e5/10342696/0c588e2d6784/jcm-12-04198-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27e5/10342696/d07714a0bbec/jcm-12-04198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27e5/10342696/0c588e2d6784/jcm-12-04198-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27e5/10342696/d07714a0bbec/jcm-12-04198-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27e5/10342696/0c588e2d6784/jcm-12-04198-g002.jpg

相似文献

1
Prevalence and Characteristics of Itch and Pain in Patients Suffering from Chronic Hand Eczema.慢性手部湿疹患者瘙痒和疼痛的患病率及特征
J Clin Med. 2023 Jun 21;12(13):4198. doi: 10.3390/jcm12134198.
2
Psychosocial Consequences of Hand Eczema-A Prospective Cross-Sectional Study.手部湿疹的心理社会后果——一项前瞻性横断面研究
J Clin Med. 2023 Sep 3;12(17):5741. doi: 10.3390/jcm12175741.
3
Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Hand Eczema in Adults.成人特应性皮炎和慢性手部湿疹的患者报告结局测量。
Patient. 2019 Oct;12(5):445-459. doi: 10.1007/s40271-019-00373-y.
4
The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial.在一项为期 16 周的随机 2b 期临床试验中,乳膏制剂的泛 JAK 抑制剂地洛格司亭在慢性手部湿疹中表现出剂量反应。
Br J Dermatol. 2022 Jul;187(1):42-51. doi: 10.1111/bjd.21037. Epub 2022 Apr 19.
5
Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.乌帕替尼治疗特应性皮炎的日常实践经验,重点关注手部湿疹:来自BioDay注册研究的结果
Contact Dermatitis. 2023 May;88(5):351-362. doi: 10.1111/cod.14276. Epub 2023 Jan 19.
6
Treatment with delgocitinib cream improves itch, pain and other signs and symptoms of chronic hand eczema: Results from the Hand Eczema Symptom Diary in a phase IIb randomized clinical trial.使用地洛昔芬乳膏治疗可改善慢性手部湿疹的瘙痒、疼痛和其他症状和体征:来自 IIb 期随机临床试验手部湿疹症状日记的结果。
Contact Dermatitis. 2023 Jul;89(1):46-53. doi: 10.1111/cod.14303. Epub 2023 Apr 10.
7
Measurement properties of the Patient-Reported Outcomes Information System (PROMIS ) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.患者报告结局信息系统(PROMIS)瘙痒问卷的测量属性:成人特应性皮炎患者的瘙痒严重程度评估
Br J Dermatol. 2020 Nov;183(5):891-898. doi: 10.1111/bjd.18978. Epub 2020 May 10.
8
Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study.电子健康智能手机应用对手足湿疹患者生活质量和临床结局的影响:前瞻性随机对照干预研究。
JMIR Mhealth Uhealth. 2023 Mar 7;11:e38506. doi: 10.2196/38506.
9
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.临床实践中特应性皮炎控制情况及瘙痒强度的测量:临床实践中湿疹统一结局测量(HOME-CP)倡议的共识声明
JAMA Dermatol. 2022 Dec 1;158(12):1429-1435. doi: 10.1001/jamadermatol.2022.4211.
10
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.阿泊替尼治疗重度和/或难治性特应性皮炎患者的疗效和安全性:随机 3 期 JADE COMPARE 试验的事后分析。
Am J Clin Dermatol. 2023 Jul;24(4):609-621. doi: 10.1007/s40257-023-00785-5. Epub 2023 May 22.

引用本文的文献

1
Development and Validation of a Patient-Reported Outcome Measure of the Impact of Chronic Hand Eczema on Health-Related Quality of Life: the Hand Eczema Impact Scale (HEIS).慢性手部湿疹对健康相关生活质量影响的患者报告结局量表的开发与验证:手部湿疹影响量表(HEIS)
Dermatol Ther (Heidelb). 2024 Nov;14(11):3047-3070. doi: 10.1007/s13555-024-01267-0. Epub 2024 Oct 21.
2
Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of Chronic Hand Eczema: The Hand Eczema Symptom Diary (HESD).用于评估慢性手部湿疹体征和症状的患者报告结局量表的开发与心理测量学验证:手部湿疹症状日记(HESD)
Dermatol Ther (Heidelb). 2024 Mar;14(3):643-669. doi: 10.1007/s13555-024-01114-2. Epub 2024 Mar 15.
3

本文引用的文献

1
Chronic hand eczema in Europe: Patient experiences and perspectives (CHEPEP) in qualitative interviews.欧洲慢性手部湿疹:定性访谈中的患者体验和观点(CHEPEP)。
J Eur Acad Dermatol Venereol. 2023 Jul;37(7):1396-1405. doi: 10.1111/jdv.19055. Epub 2023 Apr 27.
2
Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study.电子健康智能手机应用对手足湿疹患者生活质量和临床结局的影响:前瞻性随机对照干预研究。
JMIR Mhealth Uhealth. 2023 Mar 7;11:e38506. doi: 10.2196/38506.
3
Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.
Hand Eczema in High School Students in Poland: A Cross-sectional Study.波兰高中生手部湿疹:一项横断面研究。
Acta Derm Venereol. 2024 Jan 10;104:adv1367. doi: 10.2340/actadv.v104.18367.
4
Hand Eczema in the Polish Female Population.波兰女性群体中的手部湿疹
J Clin Med. 2023 Sep 21;12(18):6102. doi: 10.3390/jcm12186102.
5
Psychosocial Consequences of Hand Eczema-A Prospective Cross-Sectional Study.手部湿疹的心理社会后果——一项前瞻性横断面研究
J Clin Med. 2023 Sep 3;12(17):5741. doi: 10.3390/jcm12175741.
化脓性汗腺炎/反向性痤疮中的瘙痒:一项系统评价
J Clin Med. 2022 Jun 30;11(13):3813. doi: 10.3390/jcm11133813.
4
Lifestyle factors and hand eczema: A systematic review and meta-analysis of observational studies.生活方式因素与手部湿疹:观察性研究的系统评价和荟萃分析。
Contact Dermatitis. 2022 Sep;87(3):211-232. doi: 10.1111/cod.14102. Epub 2022 Apr 2.
5
The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial.在一项为期 16 周的随机 2b 期临床试验中,乳膏制剂的泛 JAK 抑制剂地洛格司亭在慢性手部湿疹中表现出剂量反应。
Br J Dermatol. 2022 Jul;187(1):42-51. doi: 10.1111/bjd.21037. Epub 2022 Apr 19.
6
Guidelines for diagnosis, prevention, and treatment of hand eczema.手部湿疹的诊断、预防及治疗指南。
Contact Dermatitis. 2022 May;86(5):357-378. doi: 10.1111/cod.14035. Epub 2022 Mar 3.
7
Characteristics, mechanism, and management of pain in atopic dermatitis: A literature review.特应性皮炎疼痛的特征、机制及管理:文献综述
Clin Transl Allergy. 2021 Dec;11(10):e12079. doi: 10.1002/clt2.12079.
8
Validation of the 5-D Itch Scale in Three Ethnic Groups and Exploring Optimal Cutoff Values Using the Itch Numerical Rating Scale.5-D 瘙痒量表在三个种族中的验证及使用瘙痒数字评分量表探索最佳截断值。
Biomed Res Int. 2021 Dec 13;2021:7640314. doi: 10.1155/2021/7640314. eCollection 2021.
9
Chronic pain: an update on burden, best practices, and new advances.慢性疼痛:负担、最佳实践和新进展的更新。
Lancet. 2021 May 29;397(10289):2082-2097. doi: 10.1016/S0140-6736(21)00393-7.
10
Quality of life, anxiety, depression, social anxiety and avoidance in patients with chronic hand eczema.慢性手部湿疹患者的生活质量、焦虑、抑郁、社交焦虑和回避。
Ital J Dermatol Venerol. 2021 Oct;156(5):562-569. doi: 10.23736/S2784-8671.21.06645-1. Epub 2021 Apr 29.